查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451627

2024-2032 年按细胞类型、治疗类型、治疗领域、最终用户和地区分類的细胞治疗市场报告

Cell Therapy Market Report by Cell Type, Therapy Type, Therapeutic Area, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2023年全球细胞治疗市场规模达135亿美元。展望未来， IMARC Group预计到2032年市场规模将达到505亿美元，2024-2032年复合年增长率（CAGR）为15.28%。干细胞研究的不断进步、全球医疗保健基础设施的不断完善、患者意识的提高、政府支持的不断升级以及保险覆盖范围的扩大是推动市场发展的一些因素。

细胞疗法（CT）涉及移植人体细胞以解决组织和细胞损伤，为各种医疗状况提供解决方案。这种包罗万象的方法融合了不同的细胞类型，包括造血干细胞 (HSC)、骨骼肌和间质干细胞、淋巴细胞、树突状细胞和胰岛细胞。其应用范围不仅限于增强免疫系统以治疗癌症，还包括治疗自体免疫疾病和传染病、泌尿问题、关节软骨损伤、脊髓损伤、免疫系统减弱和神经系统疾病。它在再生药物的製造中发挥关键作用，能够开发和实施旨在组织和器官修復以及受衰老、疾病或损伤影响的功能恢復的新型治疗方法。

全球市场主要由生物技术的快速进步所推动。与此一致的是，不断增加的研发活动对市场做出了重大贡献。此外，政府和私人投资者不断增加的资金推动了研究和商业化。除此之外，不断扩大的临床试验活动验证了细胞疗法的有效性和安全性，刺激了市场。此外，慢性病和退化性疾病发生率的不断上升需要先进的治疗方案，从而推动了市场的发展。人口老化需要针对与年龄相关的疾病的再生疗法，从而提振了市场。此外，针对个别患者的个人化细胞疗法正在受到关注，促进了市场成长。监管机构为细胞疗法的审批提供了更清晰的途径，为市场创造了积极的前景。竞争推动细胞治疗产品的创新与多样化。此外，罕见疾病盛行率的不断上升也推动了市场的发展。

细胞治疗市场趋势/驱动因素：

各种疾病的盛行率不断增加，例如癌症和心臟异常

各种疾病的日益流行，特别是癌症和心臟异常，对市场产生了有利的影响。由于人口老化、生活方式的改变和环境影响等因素，这些疾病的全球负担稳定上升。细胞疗法利用特殊细胞的再生和修復特性，在治疗和治癒这些疾病方面具有巨大的前景。对于癌症，基于细胞的免疫疗法，例如 CAR-T 细胞疗法，在靶向和消除癌细胞方面已取得了显着的成功。在心臟异常的情况下，基于干细胞的疗法旨在修復受损的心臟组织并改善心臟功能。对这些广泛传播且危及生命的疾病的有效治疗的迫切需要推动了对细胞治疗方法的广泛研究、开发和投资。

细胞疗法的临床研究数量不断增加

细胞疗法的临床研究数量不断增加正在推动市场成长。临床试验在验证这些创新疗法的安全性和有效性方面发挥基础作用。随着临床研究的发展，对解决癌症、自体免疫疾病和退化性疾病等各种疾病的新疗法的需求不断增长。製药公司、学术机构和生技公司正在积极进行这些试验，将细胞疗法推向市场。这些研究产生的大量资料证明了细胞疗法的治疗潜力，同时也有助于完善治疗方案和确定最合适的患者群体。此外，美国FDA等监管机构积极支持并加速细胞疗法的审批流程，进一步激励临床试验的启动。因此，越来越多的临床研究促进了细胞疗法的进步，促进了创新并扩大了对有需要的患者的可近性。这一因素强调了临床研究在推动市场方面所扮演的重要角色。

在全球拓展医疗保健产业

全球不断扩张的医疗保健产业为市场提供了许多机会。随着人口成长、老化以及慢性病负担的增加，对先进医疗的需求显着增加。医疗保健产业的扩张包括开发细胞疗法等尖端疗法。全球的医疗保健系统正在认识到细胞疗法在解决从癌症和心血管疾病到神经系统疾病和自体免疫疾病等多种医疗状况的潜力。这种认可转化为再生医学和细胞疗法领域投资、研究和临床试验的增加。此外，随着新兴经济体医疗基础设施的改善，包括细胞疗法在内的先进医疗方法变得更加容易取得。医疗保健服务的全球扩张扩大了细胞治疗的潜在患者群体，推动了市场成长。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球细胞治疗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场细分：按电池类型

  • 干细胞
    • 市场走向
    • 关键环节
      • 骨髓
      • 血
      • 脐带来源
      • 脂肪干细胞
      • 其他的
    • 市场预测
  • 非干细胞
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依治疗类型

  • 自体
    • 市场走向
    • 市场预测
  • 同种异体
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依治疗领域

  • 恶性肿瘤
    • 市场走向
    • 市场预测
  • 肌肉骨骼疾病
    • 市场走向
    • 市场预测
  • 自体免疫疾病
    • 市场走向
    • 市场预测
  • 皮肤科
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 学术及研究机构
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AlloSource
    • Anterogen Co. Ltd.
    • Cells for Cells
    • Holostem Terapie Avanzate Srl
    • JCR Pharmaceuticals
    • Kolon TissueGene Inc.
    • MEDIPOST
    • Mesoblast Limited
    • NuVasive
    • Stemedica Cell Technologies Inc.
    • Stempeutics Research Pvt. Ltd
    • Vericel Corporation
Product Code: SR112024A6231

The global cell therapy market size reached US$ 13.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 50.5 Billion by 2032, exhibiting a growth rate (CAGR) of 15.28% during 2024-2032. The increasing advances in stem cell research, the rising healthcare infrastructure across the globe, the growing patient awareness, the escalating government support, and the expanding insurance coverage are some of the factors propelling the market.

Cell therapy (CT) involves the transplantation of human cells to address tissue and cell damage, providing solutions for various medical conditions. This encompassing approach incorporates different cell types, including hematopoietic stem cells (HSC), skeletal muscle and mesenchymal stem cells, lymphocytes, dendritic cells, and pancreatic islet cells. Its applications extend beyond immune system enhancement for cancer treatment to encompass the management of autoimmune and infectious diseases, urinary issues, joint cartilage damage, spinal cord injuries, weakened immune systems, and neurological disorders. It plays a pivotal role in manufacturing regenerative medicines, enabling the development and implementation of novel treatments aimed at tissue and organ restoration and the recovery of functions impacted by aging, diseases, or injuries.

The global market is majorly driven by the rapid advancements in biotechnology. In line with this, the increasing research and development activities are significantly contributing to the market. Furthermore, the rising funding from governments and private investors fuels research and commercialization. Apart from this, the expanding clinical trial activities validate the efficacy and safety of cell therapies, catalyzing the market. Moreover, the growing incidence of chronic and degenerative diseases necessitates advanced treatment options, propelling the market. An aging demographic requires regenerative therapies for age-related conditions, bolstering the market. Besides, personalized cell therapies tailored to individual patients are gaining traction, fostering market growth. Regulatory bodies provide clearer pathways for cell therapy approvals, creating a positive outlook for the market. Competition drives innovation and diversification of cell therapy products. Additionally, the escalating prevalence of rare diseases is providing a boost to the market.

Cell Therapy Market Trends/Drivers:

Increasing prevalence of various diseases, such as cancer and cardiac abnormalities

The increasing prevalence of various diseases, particularly cancer and cardiac abnormalities, is favorably impacting the market. The global burden of these diseases has steadily risen due to factors like aging populations, lifestyle changes, and environmental influences. Cell therapy holds immense promise in treating and potentially curing these conditions by utilizing specialized cells' regenerative and reparative properties. For cancer, cell-based immunotherapies, such as CAR-T cell therapy, have shown remarkable success in targeting and eliminating cancer cells. In the case of cardiac abnormalities, stem cell-based therapies aim to repair damaged heart tissue and improve cardiac function. The urgent need for effective treatments for these widespread and life-threatening diseases propels extensive research, development, and investment in cell therapy approaches.

Rising number of clinical studies for cell-based therapies

The rising number of clinical studies for cell-based therapies is fueling the market growth. Clinical trials play a fundamental role in validating the safety and efficacy of these innovative treatments. As clinical studies grow, the demand for novel therapies to address various medical conditions such as cancer, autoimmune diseases, and degenerative disorders grows. Pharmaceutical companies, academic institutions, and biotechnology firms are actively conducting these trials to bring cell-based therapies to the market. The wealth of data generated from these studies demonstrates the therapeutic potential of cell therapies but also aids in refining treatment protocols and identifying the most suitable patient populations. Moreover, regulatory agencies like the FDA in the United States actively support and expedite the approval process for cell-based therapies, further incentivizing the initiation of clinical trials. As a result, the increasing number of clinical studies catalyzes advancing cell therapies, fostering innovation and expanding their accessibility to needy patients. This factor underscores the significant role clinical research plays in propelling the market.

Expanding healthcare industry worldwide

The expanding healthcare industry worldwide is offering numerous opportunities for the market. As populations grow, age, and face an increasing burden of chronic diseases, the demand for advanced medical treatments rises significantly. The healthcare sector's expansion includes the development of cutting-edge therapies like cell-based treatments. Healthcare systems across the globe are recognizing the potential of cell therapy in addressing a wide range of medical conditions, from cancer and cardiovascular diseases to neurological disorders and autoimmune conditions. This recognition translates into increased investment, research, and clinical trials in regenerative medicine and cell therapy. Moreover, as healthcare infrastructure improves in emerging economies, there is greater accessibility to advanced medical treatments, including cell therapies. This global expansion of healthcare services broadens the potential patient pool for cell-based treatments, driving market growth.

Cell Therapy Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cell therapy market report, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on cell type, therapy type, therapeutic area, and end user.

Breakup by Cell Type:

Stem Cell

Bone Marrow

Blood

Umbilical Cord-Derived

Adipose-Derived Stem Cell

Others

Non-stem Cell

Stem cell dominates the market

The report has provided a detailed breakup and analysis of the market based on the cell type. This includes stem cell (bone marrow, blood, umbilical cord-derived, adipose-derived stem cell, and others) and non-stem cell. According to the report, stem cell represented the largest segment.

Stem cells, with their remarkable regenerative potential and ability to differentiate into various cell types, have garnered significant attention in the medical field. These versatile cells are instrumental in treating a wide spectrum of diseases, including degenerative disorders, neurological conditions, and hematological malignancies. The increasing prevalence of age-related diseases and chronic conditions has intensified the demand for effective stem cell-based treatments. Moreover, ongoing research and clinical trials continue to unveil new therapeutic possibilities for stem cells, further fueling market growth. Pharmaceutical and biotechnology firms heavily invest in stem cell research, focusing on developing innovative therapies.

Furthermore, regulatory agencies are recognizing the importance of stem cell therapies, streamlining approval processes, and safety standards. This facilitates the commercialization of stem cell-based treatments, making them more accessible to patients worldwide. The stem cell segment is a powerful driver of growth in the cell therapy market, promising revolutionary solutions for numerous medical challenges.

Breakup by Therapy Type:

Autologous

Allogeneic

Autologous dominates the market

The report has provided a detailed breakup and analysis of the market based on the therapy type. This includes autologous and allogeneic. According to the report, autologous represented the largest segment.

Autologous therapies involve the extraction, manipulation, and reinfusion of a patient's cells, minimizing the risk of rejection and adverse reactions. This personalized approach has gained prominence in treating various conditions, including cancer, autoimmune diseases, and degenerative disorders. The increasing demand for therapies with higher safety profiles and reduced immune complications has fueled the adoption of autologous cell therapies. These treatments harness the regenerative potential of a patient's cells, addressing unmet medical needs while minimizing the risks associated with allogeneic treatments, where cells are sourced from donors.

Furthermore, advancements in cell processing techniques, such as CAR-T cell therapies for cancer treatment, showcase the remarkable potential of autologous therapies. Regulatory agencies are also streamlining approval pathways for these personalized treatments, expediting their availability to a wider patient population. As a result, the autologous therapy segment is a pivotal driver of growth in the cell therapy market, offering innovative and patient-centric solutions for various medical conditions.

Breakup by Therapeutic Area:

Malignancies

Musculoskeletal Disorders

Autoimmune Disorders

Dermatology

Others

Malignancies dominate the market

The report has provided a detailed breakup and analysis of the market based on the therapeutic area. This includes malignancies, musculoskeletal disorders, autoimmune disorders, dermatology, and others. According to the report, malignancies represented the largest segment.

Malignancies, including various types of cancer, present one of the most challenging healthcare concerns globally. Cell therapies, such as CAR-T, have emerged as groundbreaking treatments for these conditions. The growing incidence of cancer and the increasing demand for more effective and targeted therapies have propelled the development and adoption of cell-based treatments. These therapies harness the patient's immune system or engineered cells to target and eliminate cancer cells. Their remarkable success in clinical trials and real-world applications underscores their potential to transform cancer treatment.

Moreover, regulatory agencies are expediting approvals for cell therapies in oncology, streamlining their path to market. As a result, the malignancies-focused segment serves as a critical driver of growth in the cell therapy market, offering renewed hope to cancer patients and contributing to the evolution of cancer care.

Breakup by End User:

Hospitals and Clinics

Academic and Research Institutes

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, academic and research institutes.

Hospitals and clinics, with their advanced medical infrastructure and access to a broad patient base, are well-positioned to integrate cell therapy into their treatment protocols. They offer a range of cell-based treatments, including CAR-T cell therapy for cancer and stem cell therapies for various conditions, providing patients with advanced and personalized care options.

Furthermore, the collaboration between hospitals, clinics, and cell therapy companies fosters the expansion of clinical trials and the development of new therapies. As these healthcare facilities continue to recognize the potential of cell therapies in improving patient outcomes, their adoption and utilization of cell-based treatments contribute significantly to the market's overall growth.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America boasts a robust and highly developed healthcare infrastructure, including advanced research institutions, hospitals, and clinical centers. These institutions actively engage in cell therapy research and clinical trials, accelerating the development and adoption of innovative cell-based treatments. The substantial investments in the biotechnology and pharmaceutical sectors facilitate the advancement of cell therapies. Pharmaceutical companies and biotech firms in the region actively contribute to cell therapy research and development, resulting in a steady stream of new therapies.

The regulatory agencies in North America, such as the FDA in the United States, play a crucial role in streamlining the approval process for cell therapies, ensuring they meet rigorous safety and efficacy standards. This regulatory support expedites the commercialization of these treatments. Moreover, the increasing prevalence of chronic diseases, including cancer, fuels the demand for effective and advanced therapies, making cell therapies an attractive option for patients and healthcare providers.

Competitive Landscape:

Top companies are strengthening the market through multifaceted strategies and contributions. These industry leaders prioritize extensive research and development, continuously pushing the boundaries of cell therapies by exploring novel cell types, delivery methods, and applications. They conduct rigorous clinical trials, substantiating the safety and efficacy of their therapies and obtaining regulatory approvals that enhance market credibility. Strategic collaborations and partnerships with research institutions, biotech firms, and healthcare organizations allow them to leverage combined expertise and resources. Top companies often expand their market reach globally, making cell therapies accessible to a broader patient base. Maintaining strict compliance with regulatory standards ensures that their therapies meet stringent safety and quality requirements, instilling confidence among healthcare professionals and patients. Additionally, initiatives to improve patient access, educational campaigns, and strategic acquisitions collectively reinforce their pivotal role in advancing cell therapies and fostering market growth.

The report has provided a comprehensive analysis of the competitive landscape in the cell therapy market. Detailed profiles of all major companies have also been provided.

AlloSource

Anterogen Co. Ltd.

Cells for Cells

Holostem Terapie Avanzate S.r.l.

JCR Pharmaceuticals

Kolon TissueGene Inc

MEDIPOST

Mesoblast Limited

NuVasive

Stemedica Cell Technologies Inc.

Stempeutics Research Pvt. Ltd

Vericel Corporation

Recent Developments:

In July 2023, AlloSource received FDA 510(K) clearance for AceConnex pre-sutured fascia for hip labral eeconstruction and augmentation.

In June 2020, Holostem Terapie Avanzate S.r.l signed a contract for the transfer of the business branch of Holoclar, an autologous stem-cell therapy for the treatment of patients with severe ocular surface burns, with Chiesi Farmaceutici, international research-focussed group (Chiesi Group).

In October 2022, MEDIPOST announced the launch of a Contract Development and Manufacturing Organization (CDMO) business for cell and gene therapy products in Korea.

Key Questions Answered in This Report

  • 1. What was the size of the global cell therapy market in 2023?
  • 2. What is the expected growth rate of the global cell therapy market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global cell therapy market?
  • 4. What are the key factors driving the global cell therapy market?
  • 5. What is the breakup of the global cell therapy market based on the cell type?
  • 6. What is the breakup of the global cell therapy market based on the therapy type?
  • 7. What is the breakup of the global cell therapy market based on the therapeutic area?
  • 8. What are the key regions in the global cell therapy market?
  • 9. Who are the key players/companies in the global cell therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cell Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cell Type

  • 6.1 Stem Cell
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Bone Marrow
      • 6.1.2.2 Blood
      • 6.1.2.3 Umbilical Cord-Derived
      • 6.1.2.4 Adipose-Derived Stem Cell
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Non-stem Cell
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Therapy Type

  • 7.1 Autologous
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Allogeneic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Therapeutic Area

  • 8.1 Malignancies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Musculoskeletal Disorders
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Autoimmune Disorders
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Dermatology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AlloSource
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 SWOT Analysis
    • 15.3.2 Anterogen Co. Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 Cells for Cells
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Holostem Terapie Avanzate S.r.l.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 JCR Pharmaceuticals
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Kolon TissueGene Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 MEDIPOST
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Mesoblast Limited
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 NuVasive
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Stemedica Cell Technologies Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Stempeutics Research Pvt. Ltd
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Vericel Corporation
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Cell Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Cell Therapy Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cell Therapy Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Cell Therapy Market: Breakup by Cell Type (in %), 2023
  • Figure 5: Global: Cell Therapy Market: Breakup by Therapy Type (in %), 2023
  • Figure 6: Global: Cell Therapy Market: Breakup by Therapeutic Area (in %), 2023
  • Figure 7: Global: Cell Therapy Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Cell Therapy Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Cell Therapy (Stem Cell) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Cell Therapy (Stem Cell) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Cell Therapy (Non-stem Cell) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Cell Therapy (Non-stem Cell) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Cell Therapy (Autologous) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Cell Therapy (Autologous) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Cell Therapy (Allogeneic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Cell Therapy (Allogeneic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Cell Therapy (Malignancies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Cell Therapy (Malignancies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Cell Therapy (Musculoskeletal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Cell Therapy (Musculoskeletal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Cell Therapy (Autoimmune Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Cell Therapy (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Cell Therapy (Dermatology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Cell Therapy (Dermatology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Cell Therapy (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Cell Therapy (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Cell Therapy (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Cell Therapy (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Cell Therapy (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Cell Therapy (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia-Pacific: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia-Pacific: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Cell Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Cell Therapy Market: Breakup by Country (in %), 2023
  • Figure 79: Middle East and Africa: Cell Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Global: Cell Therapy Industry: SWOT Analysis
  • Figure 81: Global: Cell Therapy Industry: Value Chain Analysis
  • Figure 82: Global: Cell Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cell Therapy Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Cell Therapy Market Forecast: Breakup by Cell Type (in Million US$), 2024-2032
  • Table 3: Global: Cell Therapy Market Forecast: Breakup by Therapy Type (in Million US$), 2024-2032
  • Table 4: Global: Cell Therapy Market Forecast: Breakup by Therapeutic Area (in Million US$), 2024-2032
  • Table 5: Global: Cell Therapy Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Cell Therapy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Cell Therapy Market: Competitive Structure
  • Table 8: Global: Cell Therapy Market: Key Players